Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

The future of cancer treatment – combining stem cells and immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

3 Cheers for a Cartherics Board Member

By Karen Loudon / June 16, 2022
Bryan Williams ranked among the world’s most prominent scientists By Leigh Dayton, 16 June 2022 Cartherics is delighted to announce...
Read More

She’s an Adventurer, Advocate, Author and a Cancer Survivor

By Karen Loudon / June 9, 2022
Now Heather Hawkins is a member of the Cartherics Board By Leigh Dayton  9 June 2022 It’s official. As of...
Read More

Presentation at the Locust Walk Stem Cell Tx Conference

By carth_admin / April 8, 2022
Dr Ian Nisbet Chief Operating Officer Held in partnership with Harvard Stem Cell Institute, this virtual one-day investor and partner...
Read More